期刊文献+

外周血有核细胞DNA损伤检测在肺多原发癌患者诊断中的临床价值 被引量:3

Clinical Value of DNA Damage Detection of Peripheral Blood Mononuclear Cells in Diagnosis of Multiple Primary Lung Cancer Patients
下载PDF
导出
摘要 目的本研究旨在探讨外周血单个有核细胞DNA损伤在肺多原发癌和转移癌鉴别诊断中的临床应用价值。方法应用微量全血单细胞凝胶电泳技术(彗星实验)分别检测28例转移癌、30例肺多原发癌和29例原发肺癌患者外周血单个有核细胞DNA损伤率及损伤程度。结果转移癌组外周血单个有核细胞损伤阳性率为6.29%(176/2800),显著高于肺多原发癌组3.77%(113/3000),(χ2=18.883,P=0.000);肺多原发癌组显著高于原发肺癌组2.66%(77/2900),(χ2=5.494,P=0.019)。转移癌组外周血单个有核细胞DNA损伤的尾长、尾矩和椭圆矩分别为(44.19±13.48)μm、(4.53±1.66)和(4.64±1.50),显著高于肺多原发癌组[(34.85±8.40)μm、(3.30±1.04)和(3.54±1.03)],(P=0.000);肺多原发癌组显著高于原发肺癌组[(26.25±7.64)μm、(2.20±0.98)和(2.37±0.78)],(P=0.000)。结论检测外周血单个有核细胞DNA损伤有助于肺多原发癌与转移癌的鉴别诊断。 Objective To discuss the clinical value of DNA damage detection of peripheral blood mononuclear cells in the diagnosis of multiple primary lung cancer and metastatic carcinoma. Methods By micro-whole blood single cell gel electrophoresis assay(comet experiments), we detected DNA damage rate and damage degree of peripheral blood mononuclear cells of 28 patients with pulmonary metastasis carcinoma, 30 patients with multiple primary lung cancer, and 29 patients with primary lung cancer. ResultsDNA damage rate of peripheral blood mononuclear cell in pulmonary metastatic carcinoma group was 6.29%(176/2800), which was significantly higher than 3.77%(113/3000) in multiple primary lung cancer group(χ2=18.883, P=0.000); moreover, DNA damage rate of peripheral blood mononuclear cell in multiple primary lung cancer group was also significantly higher than 2.66%(77/2900) in primary lung cancer group(χ2= 5.494, P= 0.019). DNA damage tail length, tail moment and olive moment of patients in pulmonary metastatic carcinoma group[(44.19±13.48)μm,(4.53±1.66),(4.64±1.50)] were significantly higher than those in multiple primary lung cancer group[(34.85±8.40)μm,(3.30±1.04) and(3.54±1.03)](P=0.000); moreover, DNA damage tail length, tail moment and olive moment of patients with multiple primary lung cancer group was significantly higher than those in primary lung cancer group[(26.25±7.64)μm,(2.20±0.98) and(2.37±0.78)](P=0.000). Conclusion The detection of DNA damage in peripheral blood mononuclear cells is helpful to diagnose the difference between multiple primary lung cancer and pulmonary metastatic carcinoma.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2015年第4期373-377,共5页 Cancer Research on Prevention and Treatment
基金 国家自然科学基金(81071929)
关键词 DNA损伤 多原发肿瘤 肺癌 DNA damage Multiple primary neoplasm Lung cancer
  • 相关文献

参考文献12

  • 1车国卫,周清华.肺重复癌外科治疗新观念[J].中华医学杂志,2007,87(23):1653-1655. 被引量:3
  • 2Tabish Hussain,Ashwin Kotnis,Rajiv Sarin,Rita Mulherkar.Genetic susceptibility to multiple primary neoplasms in the upper aero-digestive tract: Genotype Score and phenotype correlation[J]. Cancer Letters . 2013 (1)
  • 3Augusto Nogueira,Joana Assis,Raquel Catarino,Rui Medeiros.DNA repair and cytotoxic drugs: the potential role of RAD51 in clinical outcome of non-small-cell lung cancer patients[J]. Pharmacogenomics . 2013 (6)
  • 4Szeto, YT,Lee, AKH,Benzie, IFF,Obied, HK.Optimized noninvasive procedures to measure DNA damage in comet assay[J]. EN . 2012 (11)
  • 5Karahalil, B,Bohr, VA,Wilson, DM.Impact of DNA polymorphisms in key DNA base excision repair proteins on cancer risk[J]. EN . 2012 (10)
  • 6Laura Marabini,Rossella Calò,Pier Braga.Protective effect of erdosteine metabolite I against hydrogen peroxide-induced oxidative DNA-damage in lung epithelial cells[J]. Arzneimittelforschung . 2011 (12)
  • 7A. Mughal,A. Vikram,P. Ramarao,G.B. Jena.Micronucleus and comet assay in the peripheral blood of juvenile rat: Establishment of assay feasibility, time of sampling and the induction of DNA damage[J]. Mut.Res.-Genetic Toxicology and Environmental Mutagenesis . 2010 (1)
  • 8Andrew R. Collins.The comet assay for DNA damage and repair[J]. Molecular Biotechnology . 2004 (3)
  • 9A. Muela Molinero,F. Jorquera Plaza,T. Ribas Ari?o,R. Malagón Rojo,V. Espinel Díez,B. Ballesteros del Río,J. L. Olcoz Go?i,J. A. Santos Calderón.Multiple malignant primary neoplasms in patients with gastric neoplasms in the health district of León/ Neoplasias primarias malignas múltiples en pacientes con cáncer gástrico en el área sanitaria de León. Rev. esp. enferm. dig . 2006
  • 10Letkova L,Matakova T,Musak L, et al.DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences. Molecular Biology . 2013

二级参考文献20

  • 1李军杰,车国卫,唐小军,周清华.同期性肝肺重复癌一例报告[J].中国肺癌杂志,2006,9(1):54-54. 被引量:1
  • 2Terzi A, Lonardoni A, Scanagatta P, et al. Lung resection for bronchogenic carcinoma after pneumonectomy : a safe and worthwhile procedure. Eur J Cardiothorac Surg, 2004, 25:456- 459.
  • 3Donington JS, Miller DL, Rowland CC, et al. Subsequent pulmonary resection for bronchogenic carcinoma after pneumonectomy. Ann Thorac Surg, 2002, 74:154-158.
  • 4Terzi A, Lonardoni A, Falezza G, et al. Completion pneumonectomy for non-small cell lung cancer: experience with 59 cases. Eur J Cardiothorac Surg, 2002, 22:30-34.
  • 5Robinson CL, Jackson CA. Multiple primary cancer of the lung. J Thorac Surg, 1958, 36:166-173.
  • 6Detterbeck FC, Jones DR, Kernstine KH, et al. Special treatment issues. Chest, 2003, 123:244-258.
  • 7Keogan MT, Tung KT, Kaplan DK, et al. The significance of pulmonary nodules detected on CT staging for lung cancer. Clin Radiol, 1993, 48:94-96.
  • 8Huang J, Behrens C, Wistuba I, et al. Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis. Ann Diagn Pathol, 2001, 5: 321- 329.
  • 9Fleisher AG, McElvaney G, Robinson CL. Multiple primary bronchogenic carcinomas: treatment and follow-up. Ann Thorac Surg, 1991,51:48-51.
  • 10Angeletti CA, Mussi A, Janni A, et al. Second primary lung cancer and relapse: treatment and follow-up. Eur J Cardiothoracic Surg, 1995, 9:607-611.

共引文献6

同被引文献56

  • 1娄诚(综述),杜智,高英堂(审校).区域癌化及其临床意义[J].国际肿瘤学杂志,2007,34(10):747-750. 被引量:7
  • 2Mun M, Kohno T. Single-stage surgical treatment of synchronous bilateral multiple lung cancers. Ann Thorac Surg, 2007, 83(3): 1146-1151.
  • 3Trousse D, Barlesi F, Loundou A, et al. Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management. 1 Thorac Cardiovasc Surg, 2007, 133(5): 1193-1200.
  • 4Chang YL, Wu CT, Lee YC. Surgical treatment of synchronous multiple primary lung cancers: experience of 92 patients. J Thorac Cardiovasc Surg, 2007, 134(3): 630-637.
  • 5Beyreuther H. Multiplicitit yon Carcinomen bei einem Fall yon sog. "Schneeberger" Lungenkrebs mit Tuberkulose. Virchows Archiv Fiir Pathologische Anatomie Und Physiologie Und Fiir Klinische Medizin,1924, 250(1-2): 230-243.
  • 6Adebonoio SA, Moritz DM, Danby CA. The results of modern surgical therapy for multiple primarylung cancers. Chest, 1997, 112(3): 693-701.
  • 7Minra Hp Nakajima N, Takahashi H, et al. [Therapeutic strategy for secondary lung cancer]. Kyobu Geka, 2010, 63(11): 956-961.
  • 8Zuin A, Andriolo LG, Marulli G, et al, Is lobectomy really more effective than sublobar resection in the surgical treatment of second primary lung cancer? EurJ Cardiothorac Surg, 2013, 44(2): e120-125; discussion e125.
  • 9Boyle JM, Tandberg DJ, Chino Jp, et al. Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis. Cancer, 2015, 121(4): 598-604.
  • 10Antakli T, Schaefer RF, Rutherford JE, et al. Second primary lung cancer. Ann Thorac Surg, 1995, 59(4): 863-866; discussion 867.

引证文献3

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部